/Investors

Luma Group

Venture capital

New York · Seed–Late Stage · 13 people tracked

Also known as LUMA GROUP ADVISOR LLC

Find your way into Luma Group

1,116 people in our graph share verified history with the Luma Group team — schools, employers, funds. One of them is your warm intro.

Vikram Chaudheryunlockedknows Negin Mohktari · together at Genoa Ventures (overlapped)
×2knows the team · via Centerbridge Partners, L.P.
knows the team · via Freenome
×8knows the team · via GENERAL INCEPTION
✨ Fox Verdict
Sign up to see your fit

Investment thesis

Luma Group invests in biotechnology companies translating breakthrough science into therapies, diagnostics, and medical devices with scalable patient impact. The firm backs teams with deep biological conviction grounded in data and clear paths to clinical translation. It applies a first-principles scientific approach and uses its proprietary AI system, LABI, to accelerate data analysis, validate breakthroughs, and identify potential. Investing across multiple stages, Luma provides more than capital, offering hands-on industry leadership to founders innovating in healthcare. Its focus spans therapeutics, diagnostics, and medical devices, with an emphasis on durable, scalable outcomes for patients.

Source: firm website, verified Sep 26, 2026.

Stage
Seed–Late Stage
HQ
New York, MA, US
Instruments
Equity
Last 12 months
2 investments
Private fund assets
$70.6M
VC funds
1
Tracked investments
12
Acquisitions
1

Team · 13 people

from the firm's website & public directories
Josh Fink· Founder & Managing Member
Jamie Kasuboski· Partner & Head of Research
Bill Ryan· Chief Financial Officerin
John Gomez· Senior Associatein
Nora McCarthy· Administrative Assistantin
Richie Santry· Chief of Staffin
Rishabh Mishra· Clinical Advisorin
Tamara Young· Executive Assistantin

Tamara Young is an Executive Assistant at Luma Group, where she supports the Founder and Co-Founder.

What they invest in

from 9 of 12 portfolio companies

Biotech ×7AI & Machine Learning ×3Consumer ×2Deep Tech ×2Digital Health ×2Fintech ×2Healthtech ×2Longevity ×2

HQs:United States×5United Kingdom×2

Investments · 12 tracked

founders shown can be your intro path

By year:2026 · 22025 · 12024 · 22023 · 16 dated

Character Biocharacterbio.cominMar 2025✓ verified

Character Bio is a patient-driven therapeutics company that combines genomics, longitudinal clinical and imaging data, and machine learning to identify genetic drivers of disease progression and develop new treatments, with a focus on polygenic diseases.

AI & Machine LearningBiotechDigital HealthJersey City, US

Cheng Zhang(CEO, Co-Founder)inMarcel van der Brug(Scientific Advisor, Co-Founder)inNick Johnson(Technology Advisor, Co-Founder)inDaniel Elgort(Chief Data and Analytics Officer)inLaura Carter(Chief Scientific Officer)inRobert Kim(Chief Medical Officer)in

Co-investorsaMoonSanofi VenturesInnovation EndeavorsCantos VenturesCatalio Capital Management, LPDuke Capital Partners+5 more

Aeovian Pharmaceuticalsaeovian.com

Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing selective small molecule inhibitors to treat rare genetic and age-related diseases caused by dysregulated cellular metabolism.

BiotechBerkeley, US

Allison J. Hulme(CEO & President)inJohn Kincaid(Chief Scientific Officer)inDavis Ryman(Executive Officer)inMicah Zajic(Executive Officer)inIan Massey(Executive Officer)Stelios Tzannis(Executive Officer, Director)

Co-investorsCoastCapCTI Life Sciences Fund L.P.FJ LabsSofinnova VenturesvenBio PartnersApollo Health Ventures+1 more

Altos Labsaltoslabs.comin𝕏

Altos Labs develops computational and scientific approaches to reverse disease through breakthrough medicines, operating research institutes focused on cell health, computation, and drug discovery.

BiotechDeep TechLongevityBay Area, US

Richard Murray(CEO and Founder)Shinya Yamanaka(Chief Scientific Advisor and Founder)Hal Barron(CEO and Founder)inRichard Klausner(Founder)Hans Bishop(President and Founder)Juan Carlos Izpisua Belmonte(Founding Scientist and Senior Vice President)in

Co-investors8VCARCH Venture PartnersGeneral Catalyst

Apollo Health Venturesapollo.vcin𝕏Jan 2026

Apollo is a venture capital firm that invests in life-science and biotechnology startups, combining entrepreneurial expertise with deep scientific knowledge to support early-stage companies in drug development and personalized medicine.

BiotechDeep TechHealthtechLongevity

Nils Regge(Co-Founder & General Partner)in

Co-investorsBLN CapitalCoastCapFJ LabsKfW CapitalTruVenturo GmbHCTI Life Sciences Fund L.P.+3 more

Arsenal Biosciencesarsenalbio.comSep 2024

Arsenal Biosciences is a clinical-stage company developing programmable cell therapies to treat solid tumors.

BiotechHealthtechMedical DevicesSouth San Francisco, US

Ken Drazan(Founder)James Ahlers(Executive Officer)Irene Pleasure(Executive Officer)Margaret Nibbi(Executive Officer)

BoardValentin Barsan(Director)Sean Parker(Director)

Co-investorsARCH Venture PartnersHitachi VenturesKleiner PerkinsOUP (Osage University Partners)SoftBank Vision FundWestlake Village BioPartners+2 more

Coultreoncoultreon.cominApr 2026 · $125M

Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.

AI & Machine LearningBiotech

Pierre Raboisson(Chief Executive Officer Chief Scientific Officer Co-founder)inMarie De Vulder(Chief Legal Officer Co-founder)inGuy Peeters(Chief Financial Officer Co-founder)inJohn-Paul Gallivan(Head of Development Co-founder)inFabrice Kolb(Head of Immunology Co-founder)inPieter Peeters(Operating & Technology Officer Co-founder)in

Co-investorsFinchley Healthcare VenturesLongwood FundSofinnova VenturesBAM ElevateForbionNovo Holdings+1 more

Curvecurve.comin𝕏Acquired

Curve Pay is a digital wallet that combines multiple bank cards into one, letting users switch which card paid for a purchase after the fact, avoid foreign exchange fees, and earn cashback on top of existing card rewards.

ConsumerFintech

Shachar Bialick(Founder & CEO)in

Co-investorsCathay InnovationCohen CircleFuel Venture CapitalHanaco Venture CapitalLifeX VenturesMouro Capital+10 more

Curveimaginecurve.comin𝕏

Curve offers a digital wallet app (Curve Pay) that consolidates a user's payment cards into one wallet, letting consumers switch the card used after a purchase, avoid foreign transaction fees, and stack cashback rewards on top of existing card benefits.

ConsumerFintech

Co-investorsSamos InvestmentsCivilization Ventures Management, LlcFirst Spark Ventures, LlcLifeX VenturesMintaka

Curve Biosciencescurvebio.cominMay 2024 · $40M

Curve Bio builds Whole-Body Intelligence models from its Whole-Body Atlas, a molecular map of the body, to power blood tests that monitor organ health in chronic disease patients.

AI & Machine LearningBiotechDigital HealthDallas, US

Nathan Hunkapiller(Founder)inProf. Shan Wang, PhD(Chief Innovation Officer and Scientific Founder)Ritish Patnaik, PhD(Chief Executive Officer)CHUBA OYOLU(Executive Officer)SHAN XIANG WANG(Executive Officer, Director)RITISH PATNAIK(Executive Officer, Director)

Co-investorsFirst Spark Ventures, LlcLifeX VenturesNZVCCivilization Ventures Management, LlcMintaka

ROME Therapeuticsrometx.comSep 2023

Boston-based biotech developing drugs against the 'dark genome'/repeatome for autoimmune disease, cancer and neurodegeneration.

Co-investorsAndreessen HorowitzARCH Venture PartnersGV (Google Ventures)Sanofi VenturesAbingworthAdvent Life Sciences+11 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

SciTheraVaccine Company

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Luma Group made?
Luma Group has 12 tracked investments, 1 of which have exited, including 3 dated in the last 24 months.
What stage does Luma Group invest at?
Luma Group invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does Luma Group focus on?
Luma Group focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
Where is Luma Group located?
Luma Group is headquartered in New York, US.

Media · Podcasts & interviews

featuring the team

Luma Group CEO Josh Fink at Semafor World Economy

Semafor Events · Josh Fink

Delivering on the Promise of Precision Medicine: A Conversation with Dr. Allison Hulme

Luma Group

AI, LABI, and How we Invest: A Conversation with Neel Madhukar, PhD and Themasap Khan, PhD

Luma Group

Reimagining Chronic Care: A Conversation with Ritish Patnaik of Curve Biosciences

Luma Group

The New Era of Multi-OMICs Therapy: A Conversation with Cheng Zhang

Luma Group

Inside the Golden Age of Biotech: A Conversation with Hans Bishop of Altos Labs

Luma Group

Images

Luma Group photoLuma Group photo

Co-investors · 2

venBio Partners

venBio is a life sciences venture capital firm that partners with industry leaders to develop novel therapeutics and technologies addressing unmet medical needs.

Apollo Health Ventures

Apollo Health Ventures is a biotech-focused investor that combines traditional funding with venture building to back transformative healthcare and longevity companies in Europe and the US.

Firms observed investing alongside Luma Group, from public investor directories. Shared companies are the overlap with Luma Group's recorded portfolio.

Similar investors

Featured in lists